squamous cell carcinoma of head and neck Clinical Research Trials

Please select a valid location from the dropdown

Found 372 clinical trials

featured

Advanced Head and Neck Squamous Cell Carcinoma

People with head and neck squamous cell carcinoma may be eligible to participate in a research study being conducted by Northwell Health.

55 views
27 Jun, 2019
1 location

featured

Advanced Head and Neck Squamous Cell Carcinoma

People with head and neck squamous cell carcinoma may be eligible to participate in a research study being conducted by Montefiore Medical Center.

24 views
20 May, 2019
1 location

featured

Photoimmunotherapy – Head and Neck Squamous Cell Carcinoma

People with head and neck squamous cell carcinoma are asked to participate in a research study being conducted by Northwell Health.

87 views
20 Feb, 2019
1 location

featured

INDUCE-3 - Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

People with Head and Neck Squamous Cell Carcinoma are asked to participate in a research study being conducted by Montefiore Medical Center.

carcinoma

squamous cell carcinoma

25 views
01 May, 2020
1 location

featured

A Phase II, Multi-Center, Single-Arm, Global Study of MEDI4736 Monotherapy in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

612 views
08 Nov, 2020
1 location

Multicentric Comparative Study Between a Conventional and an Intensive Follow up Strategy After Treatment of a Head and Neck Squamous Cell Carcinoma

than 35 year, in complete remission 2-4 months after treatment of head and neck squamous cell carcinoma Patients will be randomized after the post-treatment check-up (clinical examination and reference

cancer

squamous cell carcinoma

0 views
23 Feb, 2020

E10A for the Treatment of Squamous Cell Carcinoma of the Head and Neck

Recombinant human endostatin adenovirus injection is a novel anti-tumor gene therapy drug. E10A contains a recombinant human endostatin gene with the second-generation recombinant adenovirus as its vector. After transfection tumor cells. E10A expresses human endostatin, which inhibits vascular endothelial cell proliferation and tumor angiogenesis, and blocks tumor blood supply, thereby …

squamous cell carcinoma

paclitaxel injection

neck cancer

head and neck cancer

squamous cell carcinoma of head and neck

0 views
08 Nov, 2020
1 location

Resource Sparing Curative Radiotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck: The HYPNO Trial

The aim of the study is to test whether a resource-sparing 4-week, 20-fraction course of accelerated hypofractionated radiotherapy is non-inferior to accelerated radiotherapy delivering 33 fractions over 5.5 weeks in the treatment of patients with Stage I-IV squamous cell carcinoma of the pharynx, larynx and oral cavity with the exception …

cancer of the head

caries

squamous cell carcinoma

cancer

head and neck cancer

15 views
11 Aug, 2019
2 locations

A Study to Determine the Safety Tolerability Pharmacokinetics and Preliminary Efficacy of ABBV-368 Plus Tilsotolimod and Other Therapy Combinations in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

tilsotolimod, nab-paclitaxel, and ABBV-181 in participants with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).

22 views
24 Dec, 2020
42 locations

Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

/M) head and neck squamous cell carcinoma/cancer (HNSCC). This is a randomized, double-blind, adaptive Phase II/III study comparing a combination of GSK3359609 inducible T cell co-stimulatory

metastatic head and neck squamous cell carcinoma

squamous cell carcinoma

carcinoma of oropharynx

human papillomavirus

primary tumor

6 views
17 Jan, 2021
177 locations

Filter By

Found 372 clinical trials